Loading...
Taro Pharmaceutical Industries Ltd.
TARO•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$42.98
$0.005(0.01%)
Taro Pharmaceutical Industries Ltd. (TARO) Financial Performance & Income Statement Overview
Review Taro Pharmaceutical Industries Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.81%
↑ 9.81%
Operating Income Growth
21.42%
↑ 21.42%
Net Income Growth
111.70%
↑ 111.70%
Operating Cash Flow Growth
316.97%
↑ 316.97%
Operating Margin
7.66%
↑ 7.66%
Gross Margin
51.93%
↑ 51.93%
Net Profit Margin
10.96%
↑ 10.96%
ROE
1.98%
↑ 1.98%
ROIC
1.37%
↑ 1.37%
Taro Pharmaceutical Industries Ltd. (TARO) Income Statement & Financial Overview
Review Taro Pharmaceutical Industries Ltd.'s (TARO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $164.94M | $157.15M | $148.20M | $158.89M |
| Cost of Revenue | $77.55M | $77.26M | $74.60M | $94.81M |
| Gross Profit | $87.39M | $79.88M | $73.60M | $64.08M |
| Gross Profit Ratio | $0.53 | $0.51 | $0.50 | $0.40 |
| R&D Expenses | $20.48M | $13.59M | $14.32M | $16.14M |
| SG&A Expenses | $58.13M | $50.41M | $54.54M | $55.86M |
| Operating Expenses | $78.61M | $64.00M | $68.86M | $72.006M |
| Total Costs & Expenses | $156.16M | $141.26M | $143.46M | $166.82M |
| Interest Income | $15.83M | $15.50M | $13.97M | $10.89M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $8.22M | $7.37M | $7.61M | $7.89M |
| EBITDA | $18.06M | $23.12M | $13.97M | $6.17M |
| EBITDA Ratio | $0.11 | $0.15 | $0.09 | -$0.01 |
| Operating Income | $8.78M | $15.88M | $4.74M | -$7.92M |
| Operating Income Ratio | $0.05 | $0.10 | $0.03 | -$0.05 |
| Other Income/Expenses (Net) | $16.44M | $17.46M | $12.91M | $13.36M |
| Income Before Tax | $26.23M | $33.34M | $17.66M | $5.44M |
| Income Before Tax Ratio | $0.16 | $0.21 | $0.12 | $0.03 |
| Income Tax Expense | $11.15M | $13.14M | $9.11M | -$4.59M |
| Net Income | $15.08M | $20.21M | $8.55M | $10.03M |
| Net Income Ratio | $0.09 | $0.13 | $0.06 | $0.06 |
| EPS | $0.40 | $0.54 | $0.23 | $0.27 |
| Diluted EPS | $0.40 | $0.54 | $0.23 | $0.27 |
| Weighted Avg Shares Outstanding | $37.58M | $37.58M | $37.58M | $37.58M |
| Weighted Avg Shares Outstanding (Diluted) | $37.58M | $37.58M | $37.58M | $37.58M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan